Albany, NY -- (SBWIRE) -- 09/16/2016 -- Description

This report provides detailed analysis of Worldwide Markets for Ertapenem from 2011-2016, and provides extensive market forecasts (2016-2021) by region/country and subsectors. It covers the key technological and market trends in the Ertapenem market and further lays out an analysis of the factors influencing the supply/demand for Ertapenem, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

View Report At: http://www.marketresearchreports.biz/analysis/776407

Ertapenem is a carbapenem antibiotic marketed by Merck as Invanz. It is structurally very similar to meropenem in that it possesses a 1--methyl group. Other members of the carbapenem group (imipenem, doripenem, and meropenem) are broadly active antibacterials that are used for infections caused by difficult to treat or multidrug-resistant bacteria (such as ESBL expressing Klebsiella pneumonia). They have very short serum half-lives and must be administered by intravenous infusion every 6 to 8 hours. Ertapenem differs from other carbapenems in having a somewhat less broad spectrum of activity (not against Pseudomonas aeruginosa), and in that its extended serum half-life allows it to be administered once every 24 hours.

Download Detail Report With Complete TOC at: http://www.marketresearchreports.biz/sample/sample/776407

GCC's report, Global Ertapenem Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Ertapenem market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Ertapenem market areMerck Sharp & Dohme (USA), Savior Lifetec Corporation (Taiwan), Taizhou Yiming Pharm & Chem (China), FA&FAR Chemical (China), Jiayuan Chemicals (China), Xinxiang AndersonPharm (China).

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Ertapenem industry has been provided.

Part 1. Scope of Report
1.1 Research Methodology
1.2 Geographic Scope
1.3 Years Considered

Part 2. Introduction
2.1 Key Findings
2.2 Value Chain Analysis
2.2.2 Upstream
2.2.3 Downstream

Part 3. Manufacture
3.1 Manufacturing Process
3.2 Issues and Trends

Part 4. Cost Structure
4.1 Bill of Materials
4.2 Labor Cost
4.3 Depreciation Cost
4.4 Manufacturing Cost

Part 5. Worldwide Key Vendors
5.1 Profile
5.2 Financial Performance
5.3 Market Share Trends

Browse all latest Press Releases of Market Research Reports
at: http://www.marketresearchreports.biz/pressreleases

About MarketResearchReports.biz
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact
Mr. Nachiket
90 Sate Street,
Suite 700 Albany,
NY 12207 USA
Tel: 518-621-2074
Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz
Follow us on LinkedIn: https://www.linkedin.com/company/marketresearchreports-biz